2m 2m 2m 2m 2m 2m 2m
Dexcom (DXCM)
NASDAQ
$69.12+$0.20 (+0.29%)
Price as of Jun 23, 2026 7:57 PM EDT- $26.7BMarket Cap
- -13.49%1-Year Change
- Medical DevicesIndustry
Dexcom (DXCM)
$69.12+$0.20 (+0.29%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 4.7B +15.60% | 4.0B +11.34% | 3.6B +24.49% | 2.9B +18.84% | |
Cost of Revenue | 1.9B +16.64% | 1.6B +19.60% | 1.3B +29.87% | 1.0B +33.68% | |
Gross Profit | 2.8B +14.92% | 2.4B +6.52% | 2.3B +21.55% | 1.9B +12.06% | |
Sales and Marketing Expense | 1.3B +0.40% | 1.3B +8.47% | 1.2B +18.52% | 1.0B +23.41% | |
Research and Development Expense | -599.1M +8.45% | -552.4M +9.21% | -505.8M -204.46% | 484.2M -6.36% | |
Depreciation and Amortization Expense | 251.8M +15.66% | 217.7M +17.04% | 186.0M +19.31% | 155.9M +52.84% | |
Total Operating Expenses | 1.9B +2.82% | 1.8B +8.69% | 1.7B +13.36% | 1.5B +5.46% | |
Operating Profit | 911.8M +51.97% | 600.0M +0.38% | 597.7M +52.79% | 391.2M +47.18% | |
Interest Income | 112.7M -16.02% | 134.2M -0.59% | 135.0M N/A | N/A N/A | |
Interest Expense | -14.3M -4.03% | -14.9M -26.60% | -20.3M +9.14% | -18.6M -81.46% | |
Interest Income and Expense and Net | 98.4M -17.52% | 119.3M +4.01% | 114.7M +516.67% | 18.6M -81.46% | |
Total Nonoperating Income and Expense | 176.6M +62.02% | 109.0M -3.28% | 112.7M +526.11% | 18.0M +1,158.82% | |
Income before Taxes | 1.1B +53.51% | 709.0M -0.20% | 710.4M +81.78% | 390.8M +124.73% | |
Income Taxes | 252.1M +89.83% | 132.8M -21.37% | 168.9M +240.52% | 49.6M +158.33% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 836.3M +45.14% | 576.2M +6.41% | 541.5M +58.70% | 341.2M +120.56% | |
Net Income from Continuing Operations Applicable to Common | 1.1B +53.51% | 709.0M -0.20% | 710.4M +81.78% | 390.8M +124.73% | |
Basic EPS and Net Income | 2.14 +46.58% | 1.46 +4.29% | 1.40 +59.09% | 0.88 -45.00% | |
Diluted EPS and Net Income | 2.09 +47.18% | 1.42 +9.23% | 1.30 +58.54% | 0.82 -47.10% | |
Basic Weighted Average Shares | 390.2M -0.86% | 393.6M +1.97% | 386.0M -0.87% | 389.4M +302.69% | |
Diluted Weighted Average Shares | 405.5M -1.74% | 412.7M -3.01% | 425.5M -0.47% | 427.5M +327.07% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 917.7M +51.41% | 606.1M +7.03% | 566.3M -11.83% | 642.3M -38.98% | |
Short-Term Investments | N/A N/A | 1.7B -19.91% | 2.2B +19.34% | 1.8B +33.09% | |
Cash and Cash Equivalents and Short-Term Investments | 917.7M -60.72% | 2.3B -14.31% | 2.7B +11.17% | 2.5B +1.65% | |
Total Current Assets | 4.0B -6.23% | 4.3B -2.81% | 4.4B +20.64% | 3.7B -0.42% | |
Accumulated Depreciation | 858.8M +26.61% | 678.3M +33.16% | 509.4M +40.25% | 363.2M +56.89% | |
Property and Plant and Equipment and Net | 1.6B +16.42% | 1.3B +20.38% | 1.1B +5.45% | 1.1B +31.65% | |
Total Long-Term Assets | 278.7M +61.10% | 173.0M +130.67% | 75.0M +59.24% | 47.1M +12.14% | |
Total Assets | 6.3B -2.23% | 6.5B +3.51% | 6.3B +16.19% | 5.4B +10.86% | |
Income Taxes Payable | 55.5M +1,323.08% | 3.9M -48.00% | 7.5M +53.06% | 4.9M -16.95% | |
Total Short-Term Debt | 0 -100.00% | 1.2B N/A | 0 -100.00% | 772.6M N/A | |
Total Current Liabilities | 2.1B -26.93% | 2.9B +88.43% | 1.6B -15.40% | 1.8B +155.17% | |
Total Long-Term Debt | 1.2B +0.32% | 1.2B -49.18% | 2.4B +103.24% | 1.2B -29.66% | |
Total Long-Term Liabilities | 137.1M -7.30% | 147.9M +17.75% | 125.6M -2.10% | 128.3M +42.56% | |
Total Liabilities | 3.6B -17.98% | 4.4B +4.43% | 4.2B +28.71% | 3.3B +24.80% | |
Retained Earnings | 2.4B +52.35% | 1.6B +56.41% | 1.0B +112.84% | 479.9M +1,112.45% | |
Total Stockholders Equity | 2.7B +30.60% | 2.1B +1.64% | 2.1B -2.96% | 2.1B -5.32% | |
Total Shares Outstanding | 384.8M -1.51% | 390.7M +1.38% | 385.4M -0.23% | 386.3M +298.25% | |
Cash Flow | |||||
Cash from Operating Activities | 1.4B +45.60% | 989.5M +32.20% | 748.5M +11.80% | 669.5M +51.30% | |
Capital Expenditures | 363.5M +1.31% | 358.8M +51.65% | 236.6M -35.14% | 364.8M -6.27% | |
Cash from Investing Activities | 536.0M +358.31% | -207.5M -59.09% | -507.2M -2.74% | -521.5M +141.32% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -1.7B +129.50% | -734.8M +130.63% | -318.6M -42.33% | -552.5M -5,412.50% | |
Financials Ratio | |||||
Gross Margin | 60.10% -0.59% | 60.46% -4.32% | 63.19% -2.36% | 64.72% -5.71% | |
Operating Margin | 19.56% +31.46% | 14.88% -9.84% | 16.50% +22.73% | 13.44% +23.85% | |
Return on Assets | 13.04% +44.29% | 9.04% -2.71% | 9.29% +39.63% | 6.65% +96.87% | |
Return on Equity | 34.50% +24.86% | 27.63% +7.15% | 25.78% +65.62% | 15.57% +105.19% | |
Revenue Growth | 15.60% +37.56% | 11.34% -53.70% | 24.49% +29.97% | 18.84% -30.43% | |
Current Ratio | 1.88 +28.31% | 1.47 -48.42% | 2.84 +42.60% | 1.99 -60.98% | |
Cash Ratio | 0.43 +107.21% | 0.21 -43.20% | 0.36 +4.21% | 0.35 -76.09% | |
Debt-to-Equity Ratio | 0.45 -61.08% | 1.16 -1.33% | 1.18 +27.32% | 0.92 +22.20% | |
Debt-to-Assets Ratio | 0.20 -48.02% | 0.38 -3.11% | 0.39 +6.35% | 0.37 +4.37% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow